ADVERTISEMENT

Pharmaceutical companies

Now playing Next

French pharma giant Sanofi ups profit forecast as Dupixent sales soar

ADVERTISEMENT

ADVERTISEMENT

TOP TAGS

OLYMPIC GAMES PARIS 2024 FRANCE PARIS OLYMPICS EUROPEAN UNION EUROPEAN PARLIAMENT WILDFIRES SNCF

More about this topic

Now playing Next

This French start-up wants to use AI to get drugs to market faster

French start-up Yseop has partnered with Amazon Web Services (AWS) to use generative AI to assist pharma companies with clinical trials and drug approval.

24/05/2024

Now playing Next

As drug shortages worsen, French NGOs call for more transparency

Pharmaceutical companies’ lack of transparency leads to rising drug prices and less control over public resources, the group of health organisations say.

16/05/2024

Now playing Next

Headache for Bayer as results show fall in Q1 sales and earnings

Mixed earnings results from the German Bayer Group put the pharmaceutical giant's share prices on a rollercoaster ride in Tuesday's early trading.

14/05/2024

Now playing Next

Could a new locally produced drug help Kenya overcome deadly malaria?

The WHO approved a Kenya-based pharma company to produce a crucial antimalarial drug locally, reducing reliance on imports from India and China.

12/05/2024

ADVERTISEMENT

Now playing Next

Commission’s hospital exemption divides health sector

The inclusion of the hospital exemption for advanced therapies in the new pharmaceutical regulation does not satisfy health organizations and industry amidst accessibility concerns.

03/05/2024

Now playing Next

What is the ‘hospital exemption’, and why does it matter?

A proposed overhaul of EU pharmaceutical rules would impact on the principle of hospital exemption for advance therapies and increase the requirements to ensure uniform implementation.

03/05/2024

Now playing Next

AstraZeneca reports bumper revenue in Q1 2024 on strong drug demand

AstraZeneca continued to see strong earnings boosted primarily by its oncology branch, as well as its respiratory and immunology segment.

25/04/2024

Now playing Next

New Critical Medicines Alliance starts work to address shortages

The European Commission and Belgian Presidency launched a Critical Medicines Alliance to identify weaknesses in supply of drugs in the EU, to better prevent and react to shortages.

25/04/2024

Now playing Next

Commission approves superbug-busting antibiotic

The European Commission today (22 April) authorised a new antibiotic designed to counter anti-bacterial resistance, one of the biggest health threats the EU is currently facing.

22/04/2024

Now playing Next

Letta report highlights need for stronger healthcare sector

Strengthening health resilience is one of the pillars of Enrico Letta’s report on the Single Market to be presented to EU leaders during the special European Council in Brussels today (18 April).

18/04/2024

Now playing Next

Lawmakers seek EU-level regulation of contraceptives, abortion pills

The European Parliament includes contraceptives and abortifacients in its long-awaited position on the new EU pharmaceutical rules, intending for these to be included among items regulated at EU level.

11/04/2024

Now playing Next

Agency chief seeks help from pharmacos with medicines shortages

Greater transparency between regulators and manufacturers can foster a better understanding of supply chain vulnerabilities and reduce risks of drug shortages, European Medicines Agency (EMA) Executive Director Emer Cooke told Euronews in an interview.

04/04/2024

Now playing Next

Novo Nordisk looks to expand into heart disease treatment

The Novo Nordisk deal is due to be wrapped up in the second quarter of this year. It will help to establish the maker of Wegovy and Ozempic in the cardiovascular treatment market.

26/03/2024

Now playing Next

Parliament calls for extended regulatory protection for pharmacos

The committee on environment and public health voted to increase the Commission’s proposal for regulatory protection for new pharmaceutical legislation by one-and-a-half years.

20/03/2024

Now playing Next

Parliament approach to IP rights amid health crises raises critics

An EU-wide mechanism to override IP rights to deliver live-saving medicines during crises will prove tricky to enforce if amendments proposed by MEPs are retained, intellectual property rights experts warn.

14/03/2024

Now playing Next

Novo Nordisk expands lead on Tesla on upbeat obesity drug trial

Novo Nordisk, of anti-obesity drug Wegovy fame, reveals encouraging initial trial data for new weight loss drug that could potentially overtake Wegovy.

08/03/2024

Now playing Next

Denmark's GDP soars thanks to growing pharma sector

Denmark's gross domestic product (GDP) grew 2% in the fourth quarter of 2023, largely bolstered by the country's expanding pharmaceutical sector.

20/02/2024

Now playing Next

Novo Nordisk crossroads: Can the pharma giant address the supply woes?

Novo Nordisk faces a pivotal moment as it grapples with supply issues amid soaring demand for its weight-loss drugs. Despite impressive financial gains and market dominance, the Danish pharma giant must navigate a critical decision.

10/02/2024

Now playing Next

The Big Question

Novartis doctor on Big Pharma’s battle against climate change

If the healthcare industry was a country, it would be the fifth largest polluter on Earth.

01/02/2024

Now playing Next

Drugmaker Novo Nordisk reaches market value of $500 million

Demand for obesity drugs has pushed Novo Nordisk's share price to new highs.

31/01/2024